‘Vanderbilt Basic Sciences’
Basic Sciences names Hodges, Siciliano as Dean’s Faculty Fellows
Aug. 18, 2023—By Aaron Conley Emily Hodges, assistant professor of biochemistry, and Cody Siciliano, assistant professor of pharmacology, have been named Dean’s Faculty Fellows of the School of Medicine Basic Sciences. The Dean’s Faculty Fellows program, started in 2020, is designed to recognize the efforts of faculty in the early stages of their career. The award targets...
John Jumper, developer of AlphaFold, to present an Apex Lecture on August 30
Aug. 8, 2023—To highlight major inflection points in research, the Vanderbilt School of Medicine Basic Sciences launched the Apex Lecture Series earlier this year, which allows the Basic Sciences community to engage with researchers from around the world who are influencing the trajectory of their fields. John Jumper, BS’07, senior staff research scientist for the artificial intelligence company...
2023 Dean’s Award winners announced
Jul. 28, 2023—By Lorena Infante Lara The Office of the Dean of Basic Sciences is proud to announce the 2023 recipients of the Dean’s Award for Exceptional Achievement in Graduate Studies. This year, 10 graduate students were recognized for their high academic and scientific achievement and for the originality, significance, and rigor of their dissertation research. The...
Osheroff wins prestigious MILES Award
Jul. 7, 2023—By Leah Mann Neil Osheroff, John G. Coniglio Chair in Biochemistry and professor of biochemistry and medicine, received the Mentoring, Innovation, and Leadership in Educational Scholarship Award at the annual Asia Pacific Medical Education Conference that took place in May. In the two decades since its inception, APMEC has flourished into one of the most...
Study identifies key regulator of melanoma development
Jul. 6, 2023—Vanderbilt investigators have revealed the mechanisms by which the chemokine receptor CXCR2, is associated with melanoma tumor formation and growth — a discovery that supports the continued development of drugs that inhibit the receptor’s activity. Ann Richmond, PhD, Ingram Professor of Cancer Biology and professor of Pharmacology, is internationally known for her research on chemokines...
Arrojo e Drigo receives award for excellence in the field of islet research
Jul. 6, 2023—Rafael Arrojo e Drigo, PhD, assistant professor of Molecular Physiology and Biophysics and a faculty member of the Vanderbilt Diabetes Research Center, received the inaugural Robert L. Sorenson Young Investigator Award from the Midwest Islet Club (MIC) in recognition of his research excellence and innovation in the field of islet research. Arrojo e Drigo’s research focuses...
Vanderbilt researchers envision the potential to grow new lungs
Jul. 6, 2023—Using a four-dimensional microscope that allows them to watch a tissue putting itself together, researchers at Vanderbilt University Medical Center have achieved a rare feat in science — they have shattered a long-standing dogma about how the lung develops. Their tour de force raises the possibility that one day scientists will be able to repair damaged...
Vanderbilt launches $17 million program to advance diversity of research faculty
Jun. 21, 2023—Vanderbilt University Medical Center and Vanderbilt University are launching a $17 million multiyear transformative program with support from the National Institutes of Health (NIH) to accelerate diversity, equity, inclusion and belonging in the biomedical research community. The institutions will build on prior successes in recruitment to strengthen hiring, promotion and retention efforts for diverse, early-career...
Choosing a Project for Your New, Independent Lab
Jun. 16, 2023—Chuck Sanders Thirty years into my faculty career, I now sometimes play the game of “professionally speaking, what would I have done differently over the course of the years if I had a chance to do it all over again?” I don’t indulge in this exercise to second-guess myself or to stir up regret, but...
Richmond lab identifies a key regulator of melanoma development
Jun. 15, 2023—By Kensey Bergdorf In a continuation of previous work studying the role of chemokine receptor CXCR2 in immune cells published in Cancer Immunology Research, the lab of Ann Richmond, Ingram Professor of Cancer Biology and professor of pharmacology, has identified that same receptor as a regulator of melanoma tumor formation and growth. The new study,...